Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs

Date:

There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk’s new data is a meaningful start…

Share post:

Subscribe

Popular

More like this
Related

Alaska Airlines, flight attendants reach ‘record’ tentative labor deal

Alaska's flight attendants' tentative agreement ends a drought of...

DJT share price down nearly 50% since Trump guilty verdict

Trump Media, which trades as DJT, has lost nearly...

Tesla internal data shows company has slashed at least 14% of workforce this year

Tesla internal records viewed by CNBC suggest the company...